SEC FORM 4
—
ORAMED PHARMACEUTICALS INC. (ORMP)
Acquisition (code A) of 209,291 shares; price not stated (see filing).
Reporting Person Hexter Joshua · Officer Title COO & CBO · Transaction Code A
Traded Sep 24, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001213900-26-103538 · filed 2026-09-25 · View filing →